The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Laron Syndrome (Primary Growth Hormone Resistance or Insensitivity): The Personal Experience 1958–2003
Abstract
Clinical and laboratory investigations starting in 1958 of a group of dwarfed children resembling isolated GH deficiency but who had very high serum levels of GH led to the description of the syndrome of primary GH resistance or insensitivity (Laron syndrome) and subsequently to the discovery of its molecular defects residing in the GH receptor and leading to an inability of IGF-I generation. With the biosynthesis of IGF-I in 1986, therapeutic trials started. Continuously more and more patients are being diagnosed in many parts of the world with a variety of molecular defects. This syndrome proved to be a unique model that enables the study of the consequences of GH receptor defects, the physiopathology of GH-IGF-I disruption, and comparison of the GH-independent IGF-I effects. This review presents the personal experience gained from the study follow-up and treatment of the 60 patients followed up for many years in the Israeli cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth hormone receptor and serum binding protein: purification, cloning and expression
Leung, D. W., Spencer, S. A., Cachianes, G., Hammonds, R. G., Collins, C., Henzel, W. J., Barnard, R., Waters, M. J., & Wood, W. I. (1987) · Nature · doi:10.1038/330537a0 · Cited by 1,522
Woods, K. A., Camacho-Hübner, C., Savage, M. O., & Clark, A. J. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351805 · Cited by 1,085
Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L., Reed, M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T. E., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13215 · Cited by 802
Godowski, P. J., Leung, D. W., Meacham, L. R., Galgani, J. P., Hellmiss, R., Keret, R., Rotwein, P. S., Parks, J. S., Laron, Z., & Wood, W. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8083 · Cited by 604
Self-citationGrowth Hormone Insensitivity Associated with a STAT5b Mutation
Kofoed, E. M., Hwa, V., Little, B., Woods, K. A., Buckway, C. K., Tsubaki, J., Pratt, K. L., Bezrodnik, L., Jasper, H., Tepper, A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022926 · Cited by 525
Growth Hormone (GH) Insensitivity Due to Primary GH Receptor Deficiency
ROSENFELD, R. G., ROSENBLOOM, A. L., & GUEVARA-AGUIRRE, J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-369 · Cited by 482
A Specific Growth Hormone-Binding Protein in Human Plasma: Initial Characterization*
BAUMANN, G., STOLAR, M. W., AMBURN, K., BARSANO, C. P., & DEVRIES, B. C. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-134 · Cited by 426
Immunoassay of Human Growth Hormone in Plasma
GLICK, S. M., ROTH, J., YALOW, R. S., & BERSON, S. A. (1963) · Nature · doi:10.1038/199784a0 · Cited by 383
Herington, A. C., Ymer, S., & Stevenson, J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112507 · Cited by 317
Laron Dwarfism and Mutations of the Growth Hormone–Receptor Gene
Amselem, S., Duquesnoy, P., Attree, O., Novelli, G., Bousnina, S., Postel-Vinay, M.-C., & Goossens, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910123211501 · Cited by 316
Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature
Goddard, A. D., Covello, R., Luoh, S.-M., Clackson, T., Attie, K. M., Gesundheit, N., Rundle, A. C., Wells, J. A., & Carlsson, L. M. S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331701 · Cited by 291
A dominant-negative mutation of the growth hormone receptor causes familial short stature
Ayling, R. M., Ross, R., Towner, P., Laue, S. V., Finidori, J., Moutoussamy, S., Buchanan, C. R., Clayton, P. E., & Norman, M. R. (1997) · Nature Genetics · doi:10.1038/ng0597-13 · Cited by 231
Laron, Z., Anin, S., Klipper-Aurbach, Y., & Klinger, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)91594-x · Cited by 213
Self-citationIGF-I Is Critical for Normal Vascularization of the Human Retina
Hellstrom, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3413 · Cited by 207
Daughaday, W. H., & Trivedi, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4636 · Cited by 201
LARON, Z., PERTZELAN, A., KARP, M., KOWADLO-SILBERGELD, A., & DAUGHADAY, W. H. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-2-332 · Cited by 197
Self-citationGluckman, P. D., Gunn, A. J., Wray, A., Cutfield, W. S., Chatelain, P. G., Guilbaud, O., Ambler, G. R., Wilton, P., & Albertsson-Wikland, K. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80342-7 · Cited by 176
Pituitary dwarfism with high serum levels of growth hormone.
Laron, Z., Pertzelan, A., & Karp, M. (1968) · PubMed · Cited by 160
Self-citationABSENCE OF THE PLASMA GROWTH HORMONE-BINDING PROTEIN IN LARON-TYPE DWARFISM*
Baumann, G. P., SHAW, M. A., & Winter, R. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-4-814 · Cited by 158
Iida, K., Takahashi, Y., Kaji, H., Nose, O., Okimura, Y., Abe, H., & Chihara, K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4601 · Cited by 156
Duquesnoy, P., Sobrier, M., Duriez, B., Moal, F., Buchanan, C. R., Savage, M. O., Preece, M. A., Craescu, C. T., Blouquit, Y., & Goossens, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06392.x · Cited by 154
Guevara‐Aguirre, J., Rosenbloom, A. L., Vasconez, O., Martínez, V., Gargosky, S. E., Allen, L. G., & Rosenfeld, R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3743 · Cited by 147
Berg, M. A., Guevara‐Aguirre, J., Rosenbloom, A. L., Rosenfeld, R. G., & Francke, U. (1992) · Human Mutation · doi:10.1002/humu.1380010105 · Cited by 142
Functional Endocrinology From Birth Throuch Adolescence
Talbot, N. B., Sobel, E. H., McArthur, J. W., & Crawford, J. D. (1953) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195309000-00033 · Cited by 139
Diverse growth hormone receptor gene mutations in Laron syndrome.
Berg, M. A., Argente, J., Chernausek, S. D., Gracia, R., Guevara‐Aguirre, J., Hopp, M., Pérez‐Jurado, L. A., Rosenbloom, A. L., Toledo, S. P. A., & Francke, U. (1993) · Europe PMC (PubMed Central) · Cited by 126
Laron-Type Dwarfism (Hereditary Somatomedin Deficiency): A Review
Laron, Z. (1984) · Springer eBooks · doi:10.1007/978-3-642-69070-9_3 · Cited by 126
Self-citationGrowth curves for Laron syndrome.
Laron, Z., Lilos, P., & Klinger, B. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.6.768 · Cited by 123
Self-citationBackeljauw, P. F., & Underwood, L. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784089 · Cited by 120
Puberty in Laron type dwarfism
Laron, Z., Sarel, R., & Pertzelan, A. (1980) · European Journal of Pediatrics · doi:10.1007/bf00442408 · Cited by 118
Self-citationBackeljauw, P. F., & Underwood, L. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7381 · Cited by 116
Three Year IGF-I Treatment of Children with Laron Syndrome
Klinger, B., & Laron, Z. (1995) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1995.8.3.149 · Cited by 116
Self-citationBachrach, L. K., Marcus, R., Ott, S. M., Rosenbloom, A. L., Vasconez, O., Martínez, V., Martinez, A. L., Rosenfeld, R. G., & Guevara‐Aguirre, J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.415 · Cited by 112
Laron, Z., & Klinger, B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380176 · Cited by 107
Self-citationSpectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome
Amselem, S., Duquesnoy, P., Duriez, B., Moal, F., Sobrier, M., Valleix, S., & Goossens, M. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.4.355 · Cited by 107
Silbergeld, A., Lazar, L., Erster, B., Keret, R., Tepper, R., & Laron, Z. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01253.x · Cited by 104
Self-citationClassification of growth hormone insensitivity syndrome
Laron, Z., Blum, W. F., Chatelain, P., Ranke, M. B., Rosenfeld, R. G., Savage, M. O., & Underwood, L. E. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80120-4 · Cited by 100
Self-citationInsulin-Like Growth Factor I Improves Height in Growth Hormone Insensitivity: Two Years’ Results
Ranke, M. B., Savage, M. O., Chatelain, P. G., Preece, M. A., Rosenfeld, R. G., Blum, W. F., & Wilton, P. (2008) · Hormone Research · doi:10.1159/000184637 · Cited by 100
Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.
Amselem, S., Sobrier, M., Duquesnoy, P., Rappaport, R., Postel-Vinay, M. C., Gourmelen, M., Dallapiccola, B., & Goossens, M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115071 · Cited by 98
EFFECT OF ACUTE ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR I IN PATIENTS WITH LARON-TYPE DWARFISM
Laron, Z., Erster, B., Klinger, B., & Anin, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90236-x · Cited by 98
Self-citationIida, K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.531 · Cited by 97
Penis and testicular size in patients with growth hormone insufficency.
Laron, Z., & Sarel, R. (1970) · Acta Endocrinologica · doi:10.1530/acta.0.0630625 · Cited by 96
Self-citationWalker, J. L., Wyk, J. J. V., & Underwood, L. E. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81163-1 · Cited by 89
Klinger, V., Anin, Silbergeld, Eshet, & Laron (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00356.x · Cited by 86
Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).
Laron, Z. (1999) · PubMed · Cited by 83
Self-citationBody Fat in Laron Syndrome Patients: Effect of Insulin-Like Growth Factor I Treatment
Laron, Z., & Klinger, B. (2008) · Hormone Research · doi:10.1159/000183762 · Cited by 83
Self-citationLaron, Z., Avitzur, Y., & Klinger, B. (1995) · Metabolism · doi:10.1016/0026-0495(95)90231-7 · Cited by 76
Self-citationLaron, Z., Klinger, B., Jensen, L. T., & Erster, B. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03513.x · Cited by 76
Self-citationKranzler, J. H., Rosenbloom, A. L., Martínez, V., & Guevara‐Aguirre, J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4863 · Cited by 73
Nine Novel Growth Hormone Receptor Gene Mutations in Patients with Laron Syndrome
Sobrier, M., Moal, F., Duquesnoy, P., Kandemir, N., Yordam, N., Goossens, M., & Amselem, S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3725 · Cited by 72
IGF‐I treatment of adult patients with Laron syndrome: preliminary results
Laron, Z., & Klinger, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb01829.x · Cited by 72
Self-citationLaron, Z. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7744997 · Cited by 71
Self-citationGrowth Hormone Receptor Deficiency in Ecuador1
Rosenbloom, A. L., Guevara‐Aguirre, J., Rosenfeld, R. G., & Francke, U. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6283 · Cited by 68
Silbergeld, A., Moal, F., Klinger, B., Kanety, H., Eshet, R., Amselem, S., & Laron, Z. (1997) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1997.10.3.265 · Cited by 61
Self-citationIs the Laron Mouse an Accurate Model of Laron Syndrome?
Kopchick, J. J., & Laron, Z. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2890 · Cited by 60
Self-citationKanety, H., Karasik, A., Klinger, B., Silbergeld, A., & Laron, Z. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280144 · Cited by 59
Self-citationGrowth Hormone Receptor Deficiency in Ecuador
Rosenbloom, A. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4436 · Cited by 58
Berg, M., Peoples, R., Pérez‐Jurado, L. A., Guevara‐Aguirre, J., Rosenbloom, A., Laron, Z., Milner, R. D. G., & Francke, U. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13302.x · Cited by 56
Self-citationSerum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism
Laron, Z., Klinger, B., Erster, B., & Silbergeld, A. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1210603 · Cited by 55
Self-citationLaron, Z. (1999) · BioDrugs · doi:10.2165/00063030-199911010-00006 · Cited by 54
Self-citationDuquesnoy, P., Sobrier, M., Amselem, S., & Goossens, M. (1991) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.88.22.10272 · Cited by 53
Age at first conscious ejaculation: A milestone in male puberty.
Laron, Z., Arad, J., Gurewitz, R., Grunebaum, M., & Dickerman, Z. (1979) · Pediatric Research · doi:10.1203/00006450-197910000-00103 · Cited by 51
Self-citationWalker, J. L., Crock, P., Behncken, S. N., Rowlinson, S. W., Nicholson, L. M., BOULTON, T. J. C., & Waters, M. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4954 · Cited by 51
Age at first conscious ejaculation: a milestone in male puberty.
Laron, Z., Arad, J., Gurewitz, R., Grunebaum, M. F., & Dickerman, Z. (1980) · PubMed · Cited by 48
Self-citationScharf, A., & Laron, Z. (1972) · Hormone and Metabolic Research · doi:10.1055/s-0028-1094075 · Cited by 42
Self-citationGrowth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)
Laron, Z., Wang, X. L., Klinger, B., Silbergeld, A., & Wilcken, D. E. L. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360377 · Cited by 42
Self-citationBenbassat, C. A., Eshed, V., Kamjin, M., & Laron, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030623 · Cited by 41
Self-citationCraniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity)
Kornreich, L., Horev, G., Schwarz, M., Karmazyn, B. W., & Laron, Z. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460499 · Cited by 41
Self-citationComparative effects of GH, IGF‐I and insulin on serum sex hormone binding globulin
Gafny, M., Silbergeld, A., Kilnger, B., Wasserman, M., & Laron, Z. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02526.x · Cited by 39
Self-citationBrat, O., Ziv, I., Klinger, B., Avraham, M., & Laron, Z. (2008) · Hormone Research · doi:10.1159/000185429 · Cited by 37
Self-citationKranzler, J. H. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1953 · Cited by 36
Feinberg, M. S., Scheinowitz, M., & Laron, Z. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00642-6 · Cited by 35
Self-citationKlinger, B., Ionesco, A., Anin, S., & Laron, Z. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1270515 · Cited by 34
Self-citationLaron, Z., Suikkari, A., Klinger, B., Silbergeld, A., Pertzelan, A., Seppälä, M. T., & Koivisto, V. A. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1270351 · Cited by 29
Self-citationConsequences of not treating children with laron syndrome (primary growth hormone insensitivity).
Laron, Z. (2001) · PubMed · Cited by 26
Self-citationRenal function in Laron syndrome patients treated by insulin-like growth factor-I
Klinger, B., & Laron, Z. (1994) · Pediatric Nephrology · doi:10.1007/bf00869089 · Cited by 24
Self-citationShurka, E. Z., & Laron, Z. (1975) · PubMed · Cited by 23
Self-citationElimination Characteristics of Intravenously Administered rIGF-I in Laron-Type Dwarfs
Klinger, B., Garty, M., & Laron, Z. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457646 · Cited by 23
Self-citationGrowth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism.
Keret, R., Pertzelan, A., Zeharia, A., Zadik, Z., & Laron, Z. (1988) · PubMed · Cited by 21
Self-citationKlinger, B., Jensen, L. T., Silbergeld, A., & Laron, Z. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.7990809.x · Cited by 20
Self-citationAd, I. G., Weizman, A., Silbergeld, A., Dickerman, Z., Kaplan, B., Laron, Z., & Koch, Y. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349014 · Cited by 19
Self-citationLaron, Z., Klinger, B., & Silbergeld, A. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.2.145 · Cited by 10
Self-citation
Cited by
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., Murad, M. H., & on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) · Hormone Research in Paediatrics · doi:10.1159/000452150 · Cited by 697
Obesity as disruptor of the female fertility
Silvestris, E., de Pergola, G., Rosania, R., & Loverro, G. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0336-z · Cited by 664
The GH/IGF-1 axis in ageing and longevity
Junnila, R. K., List, E. O., Berryman, D. E., Murrey, J. W., & Kopchick, J. J. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.67 · Cited by 574
Growth Hormone Regulation of Sex-Dependent Liver Gene Expression
Waxman, D. J., & O’Connor, C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0007 · Cited by 458
Metadata
- Authors
- Laron, Z.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03
- Volume
- 89
- Issue
- 3
- Pages
- 1031-1044
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1985594739
- Cited by
- 408
- References
- 81
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.